ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ KHÔ MẮT Ở NGƯỜI LỚN TUỔI

Abstract

Objective: To evaluate the efficacy of dry eye treatment in the elderly. Subjects and Methods: This was a prospective study conducted on patients aged 50 and above diagnosed with dry eye at Central Eye Hospital from August 2023 to October 2024. Examinations included symptom assessment using the OSDI questionnaire, TBUT test, corneal staining, Schirmer I test, MGD grading, meniscus height measurement, and Meibomian gland imaging. Treatment was administered according to a specific protocol, and outcomes were evaluated at 4, 8, and 12 weeks. Results: The study included 70 eyes (35 patients), 4 males, and 31 females. Functional symptoms improved significantly after 4 weeks of treatment, with a significant decrease in the mean OSDI score (p<0.001). TBUT and corneal staining improved gradually after each treatment period. Tear secretion improved slowly with an increase in Schirmer I test values after 12 weeks and meniscus height after 8 weeks (p<0.001). Meibomian gland disease severity decreased after 8 weeks. The degree of Meibomian gland area loss did not change after treatment. Conclusion: The treatment protocol was effective in improving functional symptoms, corneal surface damage, tear secretion, and the severity of Meibomian gland disease in the study group.